Md Imtaiyaz Hassan Selected Research

Calcium-Calmodulin-Dependent Protein Kinase Type 4

5/2019	High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
1/2018	Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells.
3/2017	Binding studies and biological evaluation of β-carotene as a potential inhibitor of human calcium/calmodulin-dependent protein kinase IV.
1/2017	Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Md Imtaiyaz Hassan Research Topics

Disease

85	Neoplasms (Cancer) 11/2022 - 08/2007
26	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 11/2015
16	COVID-19 03/2022 - 01/2020
14	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2020
11	Infections 11/2022 - 07/2015
10	Inflammation (Inflammations) 01/2022 - 02/2008
7	Carcinogenesis 08/2021 - 02/2010
6	Obesity 01/2022 - 11/2015
6	Carcinoma (Carcinomatosis) 01/2019 - 08/2007
5	Disease Progression 02/2022 - 01/2021
5	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2007
5	Hypoxia (Hypoxemia) 01/2020 - 03/2016
4	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2007
4	Breast Neoplasms (Breast Cancer) 05/2020 - 07/2008
3	Diabetic Neuropathies (Diabetic Neuropathy) 06/2022 - 01/2020
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2018
3	Hemochromatosis (Bronze Diabetes) 05/2017 - 03/2016
3	Brain Hypoxia (Cerebral Hypoxia) 03/2017 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 10/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2021
2	Hypertension (High Blood Pressure) 01/2022 - 12/2021
2	Atherosclerosis 01/2022 - 01/2016
2	Eye Diseases (Eye Disease) 01/2022 - 08/2020
2	Cataract (Cataracts) 01/2022 - 08/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2020
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2017
2	Fibrosis (Cirrhosis) 12/2021 - 12/2021
2	Genomic Instability 01/2020 - 01/2019
2	Neuroblastoma 01/2019 - 01/2018
2	Mucopolysaccharidosis VII (Sly Syndrome) 01/2016 - 01/2013
1	Psychotic Disorders (Schizoaffective Disorder) 06/2022
1	Neuroinflammatory Diseases 06/2022
1	Tauopathies 06/2022

Drug/Important Bio-Agent (IBA)

55	Pharmaceutical PreparationsIBA 06/2022 - 08/2007
32	Phosphotransferases (Kinase)IBA 07/2022 - 11/2015
28	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2007
11	EnzymesIBA 02/2022 - 02/2008
9	Biological ProductsIBA 06/2022 - 01/2016
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 08/2007
7	sphingosine kinaseIBA 01/2022 - 10/2019
6	Carbonic Anhydrase IXIBA 11/2022 - 03/2016
6	AntioxidantsIBA 08/2022 - 01/2018
6	QuercetinIBA 02/2022 - 09/2019
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
5	IronIBA 01/2022 - 03/2016
4	Cyclin-Dependent Kinase 6IBA 07/2022 - 05/2020
4	Protein Kinases (Protein Kinase)IBA 01/2022 - 05/2018
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2021 - 01/2018
4	tartaric acid (tartrate)FDA Link 03/2021 - 01/2019
4	Rivastigmine (Exelon)FDA LinkGeneric 03/2021 - 01/2019
4	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2021 - 07/2019
4	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 05/2019 - 01/2017
3	naringeninIBA 07/2022 - 03/2021
3	Therapeutic UsesIBA 06/2022 - 01/2018
3	Protein Isoforms (Isoforms)IBA 01/2022 - 11/2013
3	PhytochemicalsIBA 01/2022 - 01/2018
3	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 01/2021
3	GlycosaminoglycansIBA 01/2021 - 01/2013
3	Pyruvic Acid (Pyruvate)IBA 01/2021 - 07/2019
3	tau Proteins (tau Protein)IBA 10/2020 - 01/2020
3	Prostate-Specific Antigen (Semenogelase)IBA 12/2007 - 08/2007
2	Transcription Factors (Transcription Factor)IBA 06/2022 - 03/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 08/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2020
2	Transferrin (beta 2 Transferrin)IBA 01/2022 - 01/2019
2	Crystallins (Crystallin)IBA 01/2022 - 08/2020
2	thymoquinoneIBA 01/2022 - 01/2022
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022 - 01/2018
2	caffeic acidIBA 01/2022 - 01/2022
2	LipidsIBA 12/2021 - 12/2020
2	Phosphates (Orthophosphate)IBA 04/2021 - 09/2020
2	SphingosineIBA 04/2021 - 09/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 01/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2020
2	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021 - 01/2021
2	CytokinesIBA 01/2021 - 10/2020
2	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 10/2020
2	NucleotidesIBA 01/2021 - 02/2010
2	SARS-CoV-2 3C-like proteinaseIBA 10/2020 - 01/2020
2	Donepezil (Aricept)FDA LinkGeneric 01/2020 - 01/2020
2	Superoxide Dismutase-1IBA 08/2018 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 12/2017 - 05/2017
2	Urea (Carbamide)FDA LinkGeneric 12/2017 - 10/2016
2	GlucuronidaseIBA 01/2016 - 01/2013
2	Glucuronic Acid (Glucuronate)IBA 01/2016 - 01/2013
2	Histidine (L-Histidine)FDA Link 03/2010 - 02/2010
2	Peptides (Polypeptides)IBA 05/2009 - 12/2007
2	ZincIBA 07/2008 - 08/2007
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2022
1	LipopolysaccharidesIBA 11/2022
1	ChemokinesIBA 11/2022
1	SiderophoresIBA 11/2022
1	Capsules (Microcapsules)IBA 11/2022
1	Virulence Factors (Pathogenicity Factors)IBA 11/2022
1	Serotonin (5 Hydroxytryptamine)IBA 06/2022
1	TeaIBA 06/2022
1	CaspasesIBA 06/2022

Therapy/Procedure

57	Therapeutics 11/2022 - 09/2007